CritiTech Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CritiTech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2790
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CritiTech Inc (CritiTech) is a pharmaceutical contract development manufacturing organization that specializes in particle engineering, material characterization, analytical testing, early stage drug development, pre-clinical and clinical manufacturing. The company uses Spray Drying and Supercritical Precipitation to help its customers develop their drugs. It offers contract research services such as particle engineering services, material characterization services, analytical services, and manufacturing services. CritiTech’s bioavailability optimization technology is an advanced and novel approach to the production of nanoparticulate pharmaceuticals. The company collaborates with universities, pharmaceutical companies and bio-research institutes to develop drugs. CritiTech is headquartered in Lawrence, Kansas, the US.

CritiTech Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CritiTech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CritiTech Inc, Medical Devices Deals, 2012 to YTD 2018 9
CritiTech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CritiTech Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Crititech Raises US$1.2 Million In Venture Financing 11
CritiTech Raises Additional USD0.7 Million in Venture Financing 12
CritiTech Raises US$3 Million In Venture Financing 13
Partnerships 14
DFB Pharma, CritiTech and US Biotest Form Joint Venture 14
CritiTech Enters Into Joint Venture With Finoso Pharma 15
CritiTech Inc – Key Competitors 16
CritiTech Inc – Key Employees 17
CritiTech Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
CritiTech Inc, Pharmaceuticals & Healthcare, Key Facts 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CritiTech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CritiTech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CritiTech Inc, Medical Devices Deals, 2012 to YTD 2018 9
CritiTech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Crititech Raises US$1.2 Million In Venture Financing 11
CritiTech Raises Additional USD0.7 Million in Venture Financing 12
CritiTech Raises US$3 Million In Venture Financing 13
DFB Pharma, CritiTech and US Biotest Form Joint Venture 14
CritiTech Enters Into Joint Venture With Finoso Pharma 15
CritiTech Inc, Key Competitors 16
CritiTech Inc, Key Employees 17
CritiTech Inc, Joint Venture 18

List of Figures
CritiTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CritiTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CritiTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CritiTech Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[CritiTech Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pioneer Corp:企業の戦略的SWOT分析
    Pioneer Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV) is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform …
  • Cameco Corporation:企業の戦略・SWOT・財務分析
    Cameco Corporation - Strategy, SWOT and Corporate Finance Report Summary Cameco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CITIC Pacific Limited:戦略・SWOT・企業財務分析
    CITIC Pacific Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Pacific Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Intec Pharma Ltd (NTEC):製薬・医療:M&Aディール及び事業提携情報
    Summary Intec Pharma Ltd (Intec Pharma) is a biopharmaceutical company that offers delivery solutions for drugs. The company’s pipeline products include drug indications for Parkinson’s disease, insomnia and other diseases. Its proprietary gastro retentive formulation, offers a drug delivery solutio …
  • Hanger, Inc. (HNGR):企業の財務・戦略的SWOT分析
    Hanger, Inc. (HNGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Immunicum AB (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell …
  • SK Innovation Co Ltd (096770):石油・ガス:M&Aディール及び事業提携情報
    Summary SK Innovation Co Ltd (SK Innovation) is an integrated energy and petrochemical company. It explores for and produces crude oil and natural gas; transportation of crude oil; and production of oil products such as gasoline and diesel. Through subsidiaries, the company carries out refining oper …
  • Nila Infrastructures Ltd:企業の戦略・SWOT・財務情報
    Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Peyto Exploration & Development Corp (PEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various de …
  • Hanesbrands Inc.:企業の戦略・SWOT・財務情報
    Hanesbrands Inc. - Strategy, SWOT and Corporate Finance Report Summary Hanesbrands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Zain Group:企業の戦略・SWOT・財務情報
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lebara Group:企業の戦略的SWOT分析
    Lebara Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Viriom Inc-製薬・医療分野:企業M&A・提携分析
    Summary Viriom Inc (Viriom) focuses on the development of antivirals for HIV treatment and prevention. The company’s lead pipeline product candidate Elpida, is a bioavailable prodrug, and VM-1500A, a non-nucleoside HIV reverse transcriptase inhibitor. Its partner portfolio includes Roche, ChemDiv, I …
  • PhotoMedex Inc (PHMD)-医療機器分野:企業M&A・提携分析
    Summary PhotoMedex Inc (PhotoMedex) is a medical device company that provides dermatological solutions. The company offers Neova, Tricomin and IAMIN products. Its products are used in the treatment of skin diseases and conditions such as psoriasis, vitiligo, acne, actinic keratosis. PhotoMedex provi …
  • 3W Power SA:企業の戦略的SWOT分析
    3W Power SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Gulfsands Petroleum plc (GPX):企業の財務・戦略的SWOT分析
    Summary Gulfsands Petroleum plc (Gulfsands) is an oil and gas company that offers exploration, development, and production services. The company carries out acquisition, exploration, develops, and produces oil and natural gas. It holds interests in oil exploration and development projects in the Syr …
  • OAO Tatneft:企業の戦略・SWOT・財務情報
    OAO Tatneft - Strategy, SWOT and Corporate Finance Report Summary OAO Tatneft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PowerFilm, Inc.:企業の戦略的SWOT分析
    PowerFilm, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆